Pregabalin
- Product NDC
- 69097-962
- 11-digit product format
- 690970962
- Labeler code
- 69097
- Product ID
- 69097-962_96d9d734-42e6-474d-a75e-0381de0a8ec1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PREGABALIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Cipla USA, Inc.
- Application
- ANDA211384
- Marketing category
- ANDA
- Marketing start
- 2019-07-19
- Substance
- PREGABALIN
- Active strength
- 300 mg/1
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pregabalin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PREGABALIN | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 55JG375S6M |
| Rxcui | 483438, 483440, 483442, 483444, 483446, 483448, 483450, 577127 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69097-962-05 | Pregabalin | 90 in 1 BOTTLE | CAPSULE | 90 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-962 | PREGABALIN CAPSULE [CIPLA USA, INC.] | 4 | Current NDC, Legacy NDC, 1 package rows | 20230119_17a8087c-579f-42de-ae92-006ea64def2a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-962-05 | 69097096205 | 90 CAPSULE in 1 BOTTLE (69097-962-05) | 90 capsule | 2019-07-19 | 0000-00-00 | No | No | Current |